Platinum, Palladium...
Health Care: Health Services
Mela Sciences Inc. (MELA: NASDAQ)
$0.80 -0.03 | -3.42%
06/19/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.83 |
| 52 Week High | 4.37 |
| 52 Week Low | 0.81 |
| Avg. Daily Vol. (Mil) | 0.50 |
| Beta (3 year) | -0.07 |
| Share Related Items | |
| Mkt Cap (Mil) | 35.65 |
| Shares Out (Mil) | 43.04 |
| Float (Mil) | 42.84 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 9.60 |
| Current Ratio | 10.20 |
| LT Debt/ Equity | 0.23 |
| Total Debt / Equity | 0.23 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 86.68 |
| Price/Book | 1.52 |
| Price/Cash Flow | -1.60 |
| Per Share Data | |
| Earnings | -0.71 |
| Sales | 0.01 |
| Book Value | 0.54 |
| Cash Flow | -0.51 |
| Business Summary | |
|---|---|
| MELA Sciences, Inc. is a medical device company engaged in designing and development of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. | |
| General Information | |
| 50 South Buckhout Street
Suite 1 Irvington, NY 10533 |
|
| www.melasciences.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 71 | |
| CEO: Joseph V. Gulfo,M.D. | |
| Short Interest | |
| Current Month (Mil) | 4.10 |
| Previous Month (Mil) | 4.17 |
| Short Interest Ratio (Days) | 8.20 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -73.60 |
| Return on Investments | -81.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with MELA
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor5 Stocks Under-$10 Setting ...
- ContributorBreakout Stocks Of The Week...
- UserMy Portfolio
- UserThe pick
- Usergrn8nrg Portfolio 1
Latest MELA Headlines from TheStreet
- MELA Sciences To Host Investor Meeting In Conjunction With Melanoma Monday On May 6th 2013 In New York 04.18.13 | 04:04 pm
- MELA Sciences To Participate In Upcoming 12th Annual Needham Healthcare Conference 04.15.13 | 04:04 pm
- MELA Sciences To Release First Quarter 2013 Financial Results And Host Conference Call On Tuesday, April 30, 2013 04.10.13 | 04:04 pm
- MELA Sciences Announces Fourth Quarter And Year End 2012 Financial Results 03.05.13 | 04:03 pm
- MELA Sciences Prices Public Offering Of Common Stock; Termination Of At The Market (ATM) Equity Offering Program; And Execution Of Term Sheet For Debt Financing 02.12.13 | 08:02 am
- MELA Sciences To Release Fourth Quarter And Year End 2012 Financial Results And Host Conference Call On Tuesday, March 5, 2013 02.04.13 | 08:02 am
- MELA Sciences To Present At Upcoming Investor Conferences 01.28.13 | 08:01 am
- 4 Biotech Stocks Spiking on Unusual Volume 01.08.13 | 02:01 pm
- MELA Sciences' CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.08.12 | 05:08 pm
- Biotech Stock Mailbag: Mela, Osiris, Talon 08.03.12 | 06:08 am
Press Releases for MELA
- MELA Sciences, Inc. Presents New Data That Reinforces The Importance Of MelaFind® As A Diagnostic Tool At AAD Meeting - PR Newswire 03.18.13 | 09:03 am
- Epidemic Increases In Melanoma Rates Three Of Four Americans Surveyed Have Never Had Skin Cancer Examination - PR Newswire 02.21.13 | 07:02 am
- MELA Sciences To Participate In Upcoming 15th Annual Needham Growth Conference - PR Newswire 01.04.13 | 08:01 am
- MELA Sciences Names Rpr Marketing Communications As Its New Agency Of Record - PR Newswire 01.03.13 | 08:01 am
- Potential Shareholder Claims Against Mela Sciences Investigated By Goldfarb Branham Law Firm LLP - Business Wire 12.01.10 | 09:12 am
- The Law Office Of Robbins Umeda LLP Announces An Investigation Of MELA Sciences, Inc. - Business Wire 11.18.10 | 01:11 pm
- Bronstein, Gewirtz & Grossman, LLC Investigating Possible Securities Law Violations At MELA Sciences, Inc. - Business Wire 11.17.10 | 02:11 pm
- Kahn Swick & Foti, LLC And Former Louisiana Attorney General Announce Investigation Into MELA Sciences, Inc. - MELA - Business Wire 11.16.10 | 06:11 pm
Partner Headlines for MELA
- MELA Sciences Pops 10% on Positive Results in German Clinical Study - Benzinga 07.09.12 | 01:07 pm
- MELA Sciences to Sell $20M Shares Through 'at-the-market' Equity Offering Program - Benzinga 06.15.12 | 07:06 pm
- Verisante Technology: The Future Of Cancer Detection - Seeking Alpha 11.21.11 | 08:11 am
- Company News for September 27, 2011 - Corporate Summary - Zacks 09.27.11 | 10:09 am
- Notable Put Options Activity in MELA Sciences - Benzinga 09.27.11 | 09:09 am
- Morning Market Movers - Benzinga 09.26.11 | 09:09 am
- Company News for September 8, 2011 - Corporate Summary - Zacks 09.08.11 | 10:09 am
- Morning Market Movers - Benzinga 09.07.11 | 09:09 am
- 4 Small Caps Likely to Rebound? - Seeking Alpha 12.12.10 | 09:12 am
- Friday Options Recap - Seeking Alpha 11.19.10 | 03:11 pm
